Cancer Family
Neoplasm
CI-CAN-00000001Explore in graph →
Non-malignant22,961 active trials259 approved drugs4,031 evidence items
Loading cancer entity…
Loading cancer entity…
Cancer Family
CI-CAN-00000001Explore in graph →
Clinical trials
105,853 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.
| NCT | Title | Status | Phase | Enrollment (n) | Sponsor | Countries | Last update | Source |
|---|---|---|---|---|---|---|---|---|
| NCT02236910 | An Open Label Registry Study of Lutetium-177 (DOTA0, TYR3) Octreotate (Lu-DOTA-TATE) Treatment in Patients with Somatostatin Receptor Positive Tumours | unknown | Phase 2 | 66 | London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph'sOTHER | 1 | Oct 15, 2024 | clinicaltrials |
| NCT06121752 | Device Assisted Full Thickness Resection Versus Endoscopic Submucosal Dissection for Duodenal Neuroendocrine Tumors(DNET) | unknown | N/A | 54 | Asian Institute of Gastroenterology, India |
| 1 |
| Oct 15, 2024 |
| clinicaltrials |
| NCT04675138 | Development of a Clinical Decision Support System With Artificial Intelligence for Cancer Care | unknown | — | 1,000 | National University Hospital, SingaporeOTHER | 6 | Oct 10, 2024 | clinicaltrials |
| NCT01818323 | Phase I Trial: T4 Immunotherapy of Head and Neck Cancer | unknown | Phase 1 | 30 | King's College LondonOTHER | 1 | Oct 9, 2024 | clinicaltrials |
| NCT06037174 | Comparison of Quality of Life in Patients with Differentiated Thyroid Carcinoma Undergoing Different Surgery | unknown | — | 230 | Sun Yat-Sen Memorial Hospital of Sun Yat-Sen UniversityOTHER | 1 | Oct 3, 2024 | clinicaltrials |
| NCT06465277 | CMR Right Ventricular Contractile Reserve Following Lung Resection | unknown | — | 42 | Belfast Health and Social Care TrustOTHER | 1 | Oct 3, 2024 | clinicaltrials |
| NCT06624813 | Partial Prostatectomy for Prostate Cancer(P-RALP) | unknown | N/A | 50 | Instituto do Cancer do Estado de São PauloOTHER | 1 | Oct 3, 2024 | clinicaltrials |
| NCT04913337 | Study of NGM707 As Monotherapy and in Combination with Pembrolizumab in Advanced or Metastatic Solid Tumor Malignancies | unknown | Phase 1 / Phase 2 | 179 | NGM Biopharmaceuticals, IncINDUSTRY | 3 | Oct 2, 2024 | clinicaltrials |
| NCT06623786 | Cancer Patient Remote Monitoring for Timely Communication Study(CONNECT) | unknown | — | 100 | Asklepios proresearchINDUSTRY | 0 | Oct 2, 2024 | clinicaltrials |
| NCT06322095 | A Study of GH21 Combined With Previous Target Therapy or Immunotherapy in Patients With Advanced Solid Tumors | unknown | Phase 2 | 72 | Suzhou Genhouse Bio Co., Ltd.OTHER | 1 | Oct 1, 2024 | clinicaltrials |
| NCT06621459 | Retrospective Observational Study of the Safety and Toxicity Management of Abemaciclib in Combination with Adjuvant Hormone Therapy in Patients with RH+ ,HER2-nonoveramplified Breast Cancer, Real-life Data (MONARCHE29)(MONARCHE29) | unknown | — | 30 | University Hospital, BrestOTHER | 1 | Oct 1, 2024 | clinicaltrials |
| NCT06413615 | A Study of FDA022-BB05 in Advanced/Metastatic Solid Tumors | unknown | Phase 2 | 150 | Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Co., Ltd.INDUSTRY | 1 | Sep 26, 2024 | clinicaltrials |
| NCT06406166 | Lifei Xiaoji Wan in Treatment of Advanced NSCLC | unknown | N/A | 100 | Henan University of Traditional Chinese MedicineOTHER | 1 | Sep 25, 2024 | clinicaltrials |
| NCT06613308 | Association Between Microbiome and the Efficacy and Safety of PD-1/PD-L1 Blockade in Resectable NSCLC | unknown | — | 20 | Capital Medical UniversityOTHER | 0 | Sep 25, 2024 | clinicaltrials |
| NCT06215885 | Multi-omics Analysis to Characterize the Invasive Evolution of Pulmonary Subsolid Nodules | unknown | — | 220 | Cancer Institute and Hospital, Chinese Academy of Medical SciencesOTHER | 1 | Sep 24, 2024 | clinicaltrials |
| NCT06403709 | Irinotecan, TAS-102 Plus Bevacizumab as a Third-Line or Beyond Therapy in mCRC Patients | unknown | Phase 2 | 35 | Cancer Institute and Hospital, Chinese Academy of Medical SciencesOTHER | 1 | Sep 24, 2024 | clinicaltrials |
| NCT06607120 | Prognosis Stratification for Advanced HCC Receiving TACE with PD-1/PD-L1 Inhibitors and Molecular Target Therapies | unknown | — | 950 | Zhongda HospitalOTHER | 1 | Sep 23, 2024 | clinicaltrials |
| NCT06608043 | Reborn Lifestyle Adjustment Program | unknown | — | 60 | Atlas UniversityOTHER | 1 | Sep 23, 2024 | clinicaltrials |
| NCT06565858 | Physical Activity and Sarcoma, Role and Impact on Outcome | unknown | — | 750 | European Institute of OncologyOTHER | 1 | Sep 20, 2024 | clinicaltrials |
| NCT03018418 | Proton Therapy in Reducing Toxicity in Anal Cancer | unknown | Phase 2 | 14 | Jordan KharofaOTHER | 1 | Sep 19, 2024 | clinicaltrials |
| NCT05625737 | Fruquintinib Combined with Sintilimab As Second-line Therapy for Gastric or Gastro-esophageal Junction Adenocarcinoma | unknown | Phase 2 | 29 | Union Hospital, Tongji Medical College, Huazhong University of Science and TechnologyOTHER | 1 | Sep 19, 2024 | clinicaltrials |
| NCT05793333 | Predictors of Node Positivity in Endometrial Cancer | unknown | — | 200 | Fondazione IRCCS Istituto Nazionale dei Tumori, MilanoOTHER | 1 | Sep 19, 2024 | clinicaltrials |
| NCT06210724 | FIT in Diverticulitis | unknown | — | 275 | Royal Surrey County Hospital NHS Foundation TrustOTHER | 1 | Sep 19, 2024 | clinicaltrials |
| NCT06503432 | The Effects of Programmed Death-ligand 1 on Postoperative Pain for Lung Cancer Patients | unknown | — | 100 | Peking University People's HospitalOTHER | 1 | Sep 19, 2024 | clinicaltrials |
| NCT06586697 | First-line Treatment for ES-SCLC with Chemotherapy Combined with PD-1/PD-L1 Inhibitor Sequential Thoracic Radiotherapy | unknown | Phase 2 | 47 | Henan Cancer HospitalOTHER_GOV | 1 | Sep 19, 2024 | clinicaltrials |
| NCT06587152 | Clinical Trial to Evaluate the Efficacy and Safety of a Thoracic and Abdominal Endoscopic Surgical System | unknown | N/A | 60 | Cornerstone RoboticsINDUSTRY | 1 | Sep 19, 2024 | clinicaltrials |
| NCT06590194 | PH009-1 in Patients With EGFR Mutation Locally Advanced or Metastatic Non-small Cell Lung Cancer (NSCLC) | unknown | Phase 1 / Phase 2 | 96 | Suzhou Puhe Pharmaceutical Technology Co., LTDINDUSTRY | 1 | Sep 19, 2024 | clinicaltrials |
| NCT06590844 | "cindilizumab + Bevacizumab + Coenzyme I for Injection" in Unresectable Hepatocellular Carcinoma | unknown | Phase 4 | 37 | Anhui Provincial HospitalOTHER_GOV | 1 | Sep 19, 2024 | clinicaltrials |
| NCT06590948 | Clinical Application of Quantitative Major Imaging Features of CEUS LI-RADS | unknown | — | 50 | Second Affiliated Hospital, Zhejiang University, School of MedicineOTHER | 1 | Sep 19, 2024 | clinicaltrials |
| NCT06593899 | The Total Neoadjuvant Therapy for Soft Tissue Sarcoma of the Extremities | unknown | Phase 2 | 51 | Fujian Medical University Union HospitalOTHER | 1 | Sep 19, 2024 | clinicaltrials |
| NCT06598046 | A Single-arm, Prospective Phase Ⅱ Clinical Study of Utidelone Combined with Capecitabine in the Treatment of Active Brain Metastasis of TNBC | unknown | Phase 2 | 48 | Henan Cancer HospitalOTHER_GOV | 1 | Sep 19, 2024 | clinicaltrials |
| NCT06598085 | Clinical Trial Protocol to Evaluate the Efficacy and Safety of Laparoscopic Surgical Systems for Gynaecological Surgery | unknown | N/A | 20 | Cornerstone RoboticsINDUSTRY | 1 | Sep 19, 2024 | clinicaltrials |
| NCT05116579 | Circulating Tumor DNA (ctDNA) Monitoring in the Assessment and Prediction of the Efficacy of PARP Inhibitors (PARPi) | unknown | — | 30 | Sun Yat-sen UniversityOTHER | 1 | Sep 5, 2024 | clinicaltrials |
| NCT05991947 | Preliminary Experimental Study on Key Technologies for Early Screening of Gastric Cancer | unknown | — | 1,100 | Zhejiang Cancer HospitalOTHER | 1 | Sep 5, 2024 | clinicaltrials |
| NCT06584877 | Investigating How Childhood Tumours and Congenital Disease Develop | unknown | — | 600 | The Wellcome Sanger InstituteOTHER | 1 | Sep 5, 2024 | clinicaltrials |
| NCT06585124 | Flow Cytometry for the Study of T-Cell Populations in Hemophagocytic Lymphohistiocytosis Associated With Lymphomas(LA-HLH) | unknown | — | 150 | Fondazione Policlinico Universitario Agostino Gemelli IRCCSOTHER | 1 | Sep 5, 2024 | clinicaltrials |
| NCT05099978 | Asian Multicenter Prospective Study of ctDNA Sequencing(A-TRAIN) | unknown | — | 506 | National Cancer Center, JapanOTHER_GOV | 8 | Sep 4, 2024 | clinicaltrials |
| NCT06481566 | Efficacy and Safety of Almonertinib Combined With Stereotactic Body Radiotherapy (SBRT) in the Treatment of Non-small Cell Lung Cancer With EGFR Sensitive Mutation: a Single-arm, Open-label Clinical Trial | unknown | N/A | 30 | Chongqing University Cancer HospitalOTHER | 1 | Sep 4, 2024 | clinicaltrials |
| NCT06579625 | The Effect of Health Belief Model-Based Cancer Education on Cancer Information Load, Knowledge and Attitudes Towards Cancer Screenings | unknown | N/A | 79 | Ankara UniversityOTHER | 1 | Sep 3, 2024 | clinicaltrials |
| NCT06581107 | Validate the Safety and Feasibility of the CT-guided Interventional Robot in Percutaneous Lung Cryablation Procedures | unknown | N/A | 20 | Tianjin Medical University Cancer Institute and HospitalOTHER | 1 | Sep 3, 2024 | clinicaltrials |
| NCT06581718 | Eye Gaze Technology for Endoscopic Inspection of the Gastrointestinal Tract | unknown | N/A | 10 | Imperial College LondonOTHER | 1 | Sep 3, 2024 | clinicaltrials |
| NCT03225417 | Ixazomib in the Prophylaxis of Chronic Graft-versus-host Disease. | unknown | Phase 1 / Phase 2 | 142 | Fundación Pública Andaluza para la gestión de la Investigación en SevillaOTHER | 1 | Aug 30, 2024 | clinicaltrials |
| NCT06520111 | CRISAL Study:Cancer Risk In Secreting Adrenal Lesions(CRISAL) | unknown | — | 300 | University of Roma La SapienzaOTHER | 1 | Aug 30, 2024 | clinicaltrials |
| NCT06578988 | Use of Artificial Intelligence in the Symptomatic BReAst Clinic SEtting | unknown | — | 25,000 | Royal Marsden NHS Foundation TrustOTHER | 1 | Aug 30, 2024 | clinicaltrials |
| NCT03557619 | A Study to Assess the Effect of Venetoclax on Ethinyl Estradiol and Levonorgestrel in Female Participants With Different Hematological Malignancies | unknown | Phase 1 | 12 | AbbVieINDUSTRY | 2 | Aug 29, 2024 | clinicaltrials |
| NCT06577272 | Title of Manuscript: Development and Internal-external Validation of a Comprehensive Model for Predicting Risk of Post-RFA Recurrence in HCC Patients | unknown | — | 6,000 | Tian'an JiangOTHER | 1 | Aug 29, 2024 | clinicaltrials |
| NCT06577311 | Evaluating the Use of Photodynamic Therapy to Treat Facial Cutaneous Squamous Cell Carcinoma in Situ (SCCis) | unknown | Phase 2 | 20 | The Center for Clinical and Cosmetic ResearchOTHER | 1 | Aug 29, 2024 | clinicaltrials |
| NCT06577844 | Evaluation of the Contribution of a DEMaterialized VIdeo-pedagogical SUpport in the Care Pathway of Lung Cancer Surgery Patients(SUVIDEM) | unknown | N/A | 226 | Assistance Publique Hopitaux De MarseilleOTHER | 1 | Aug 29, 2024 | clinicaltrials |
| NCT06578858 | Immunonutrition and Psychosocial Factors in the Recovery of Patients After Gastrectomy: a Multidimensional Analysis | unknown | — | 40 | Universidade Federal de PernambucoOTHER | 1 | Aug 29, 2024 | clinicaltrials |
| NCT00080756 | Deslorelin Combined With Low-Dose Add-Back Estradiol and Testosterone in Preventing Breast Cancer in Premenopausal Women Who Are at High Risk for This Disease | unknown | Phase 2 | 11 | City of Hope Medical CenterOTHER | 1 | Aug 28, 2024 | clinicaltrials |
Data updated 22 days agoSource updated Oct 15, 2024source: clinicaltrials